Fluctuation test5 2 la Luria and Delbruck were performed with mouse LMTK cells, and the result3 indicate that the appearance of variants resistant to cadmium i s due to random spontaneous mutations and not to epigenetic events. The rate of spontaneous mutations leading to cadmium resistance was calc
Amplification of the metallothionein-1 and metallothionein-2 genes in copper-resistant hepatoma cells
β Scribed by Mark J. Czaja; Francis R. Weiner; Jonathan H. Freedman
- Publisher
- John Wiley and Sons
- Year
- 1991
- Tongue
- English
- Weight
- 623 KB
- Volume
- 147
- Category
- Article
- ISSN
- 0021-9541
No coin nor oath required. For personal study only.
β¦ Synopsis
The molecular basis for increased metallothionein concentrations in copperresistant hepatoma cells was examined. The copper-resistant cell line HAC, , , , which is maintained in 600 k m copper, had increased steady-state mRNA levels for both the metallothionein-1 (MT-1) and the metallothionein-2 (MT-2) genes. Levels of mRNA were increased 11 -fold for MT-1 and 15-fold for MT-2, with no significant change in a-tubulin mRNA content. HACbqoNM cells, which are copper-resistant cells kept in a normal copper concentration for over 1 year, also had eight-and tenfold increases in MT-1 and MT-2 mKNA levels. Nuclear run-on assays showed that MT-1 and MT-2 gene transcription was increased nine-and eightfold in HAC, , , cells and seven-and tenfold in HAC, , , NM cells, respectively. Southern blot analysis showed amplification of both metallothionein genes in HAC, , , and HAC, , , NM cells. Thus the molecular basis of increased metallothionein in these hepatoma cells involved a stable gene amplification of both MT genes. The greater increase in metallothionein mRNA levels in HAC,,, cells relative to the changes in transcription suggests that posttranscriptional mechanisms of gene regulation may also be acting in these cells.
π SIMILAR VOLUMES
## Abstract The human prostate gland has low basal expression of the metallothioneinβ1 and β2 proteins. In prostate cancer, MTβ1/2 protein expression is variable and correlates directly with the increasing Gleason score of the tumor. The goal of the present study was to determine if the RWPEβ1 cell
Molecular cytogenetic studies were conducted on three multidrug-resistant cancer sublines which are highly resistant to the chemotherapeutic agent mitoxantrone, an anthracenedione. The three independently selected sublines were derived by exposure to mitoxantrone or Adriamycin and do not overexpress
## Abstract The __enhancer of zeste homolog 2__ (__EZH2__) gene has been recently linked to human malignancies where it may serve as a new target for cancer therapy. Here, we analyzed __EZH2__ expression in primary renal cell carcinoma (RCC) specimens and in nontumorous tissue samples from adult ki